Unitedhealth Group Inc (UNH) Stock Price & Analysis
Unitedhealth Group Inc (UNH) rose 1.58% to USD 413 as of June 9, 2026 at 22:42 UTC, according to Nexqual real-time market data.
UNH last closed at USD 406.57; the session ranged USD 407.44–413 on volume of 8,578,348 shares. Market capitalization is $375.06B, with a 52-week range of USD 234.6–413 (NYQ). Source: Nexqual, June 9, 2026 at 22:42 UTC.
Key Statistics (as of June 9, 2026 at 22:42 UTC)
| Price | USD 413 |
|---|---|
| Change | ▲ 1.58% (up) |
| Previous Close | USD 406.57 |
| Open | USD 409.99 |
| Day Range | USD 407.44 – 413 |
| 52-Week Range | USD 234.6 – 413 |
| Volume | 8,578,348 shares |
| Market Cap | $375.06B |
| Exchange | NYQ |
Technical Analysis (UNH)
Nexqual's technical model rates UNH "BUY" based on 5 bullish and 3 bearish signals across 124 daily candles, as of June 9, 2026 at 22:42 UTC.
| Overall Signal | BUY |
|---|---|
| RSI (14) | 73.5 (overbought) |
| vs SMA50 | Above (USD 355.43) |
| MACD | 11.36 (positive) |
Analyst Ratings (UNH)
Wall Street analysts rate UNH "Buy" based on 26 analysts, with a mean price target of USD 404.85 (range USD 287–492), per Nexqual as of June 9, 2026 at 22:42 UTC.
| Consensus Rating | Buy |
|---|---|
| Analyst Count | 26 |
| Mean Target | USD 404.85 |
| High Target | USD 492 |
| Low Target | USD 287 |
| Buy / Hold / Sell | 23 / 4 / 1 |
Earnings (UNH)
| Next Earnings Date | 2026-07-28 |
|---|---|
| EPS Estimate | USD 4.85 |
| Revenue Estimate | $110.95B |
Recent Earnings History
| Quarter | Actual vs Estimate |
|---|---|
| 2026-03-31 | USD 7.23 vs est 6.6 ▲ beat |
| 2025-12-31 | USD 2.11 vs est 2.11 ▲ beat |
| 2025-09-30 | USD 2.92 vs est 2.81 ▲ beat |
| 2025-06-30 | USD 4.08 vs est 4.45 ▼ miss |
Source: Nexqual, June 9, 2026 at 22:42 UTC.
Financials & Fundamentals (UNH)
| Total Revenue | $449.71B |
|---|---|
| Revenue Growth (YoY) | +2.00% |
| Gross Margin | +18.80% |
| Operating Margin | +8.05% |
| Profit Margin | +2.68% |
| ROE | +12.18% |
| Debt / Equity | 73.98 |
| Current Ratio | 0.8 |
| Total Cash | $31.23B |
| Total Debt | $77.92B |
| Free Cash Flow | $17.69B |
Source: Nexqual, June 9, 2026 at 22:42 UTC.
Financial Health Score (UNH)
Nexqual rates Unitedhealth Group Inc's overall financial health "Mixed" across five dimensions, as of June 9, 2026 at 22:42 UTC.
| Growth | Solid — Revenue +12% YoY (annual) |
|---|---|
| Profitability | Mixed — Gross margin 19%, operating 8% |
| Balance Sheet | Mixed — $31.2B cash vs $77.9B debt |
| Cash Flow | Mixed — FCF $17.7B, slim 4.0% margin |
| Efficiency | Mixed — ROE 12%, ROA 3.8% |
Ownership (UNH)
| Insider Ownership | +0.24% |
|---|---|
| Institutional Ownership | +85.91% |
| Shares Outstanding | 908.14M |
| Float | 905.44M |
| Short % of Float | +2.14% |
Source: Nexqual, June 9, 2026 at 22:42 UTC.
Leadership (UNH)
Unitedhealth Group Inc is led by Stephen J. Hemsley (age 72), CEO & Non-Independent Non-Executive Chairman, per Nexqual as of June 9, 2026 at 22:42 UTC.
| CEO & Non-Independent Non-Executive Chairman | Stephen J. Hemsley (age 72) |
|---|---|
| Chief Financial Officer | Wayne Scott DeVeydt (age 55) |
| Senior Vice President of Capital Markets Communications & Investor Relations | Zachary William Sopcak |
| Executive Vice President & Senior Advisor | Richard J. Migliori (age 68) |
Major Backers & Investors (UNH)
Notable institutional backers of Unitedhealth Group Inc include Capital Group, Price (T.Rowe) Associates Inc, Charles Schwab Investment Management, Inc., according to Nexqual as of June 9, 2026 at 22:42 UTC.
Active Investors
| Investor | Stake |
|---|---|
| Capital Group | 4.94% |
| Price (T.Rowe) Associates Inc | 2.3% |
| Charles Schwab Investment Management, Inc. | 2.29% |
| JPMorgan | 2.1% |
| Fidelity | 1.28% |
| WASHINGTON MUTUAL INVESTORS FUND | 1.03% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| Vanguard Group | 15.75% |
| BlackRock | 9.38% |
| State Street | 6.18% |
| Geode Capital | 2.51% |
Source: Nexqual, June 9, 2026 at 22:42 UTC.
From Unitedhealth Group Inc's Latest SEC 10-K Filing (filed 2026-03-02)
Key Strengths & Strategy (as disclosed to the SEC)
- UnitedHealth Group Incorporated operates as a health care company in the United States and internationally.
- It operates through four segments: Optum Health, Optum Insight, Optum Rx; and UnitedHealthcare.
- The Optum Health segment provides care delivery, care management, wellness and consumer engagement, and health financial services with patients, consumers, care delivery systems, providers, employers, payers, and public-sector entities.
- The Optum Insight segment offers software and information products, advisory consulting arrangements, and managed services outsourcing contracts to hospital systems, physicians, health plans, public entities, life sciences companies and other organizations.
Source: SEC EDGAR 10-K, official filing. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| LLY | Eli Lilly and Company | USD 1,144.68 | ▲ 1.17% |
| V | Visa Inc. | USD 325.05 | ▲ 0.46% |
| AVGO | Broadcom Inc. | USD 392.16 | ▲ 1.67% |
| CRM | Salesforce, Inc. | USD 175.35 | ▼ 5.55% |
| COST | Costco Wholesale Corporation | USD 968.59 | ▼ 0.34% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 9, 2026 at 22:42 UTC. This page is informational and not investment advice.